Income Statement - Anbio Biotechnology (NNNN)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | |
|---|---|---|---|---|---|
| Total revenue | 9.76 | 8.19 | 6.71 | 23.54 | 4.43 |
| Cost of revenue | 1.25 | 2.30 | 3.35 | 10.98 | 1.89 |
| Gross profit | 8.51 | 5.89 | 3.36 | 12.56 | 2.54 |
| Total operating expenses | 2.00 | 3.89 | 1.40 | 2.37 | 0.09 |
| Operating income | 6.51 | 2.00 | 1.96 | 10.20 | 2.46 |
| Non-operating income (net) | 0.72 | 0.38 | 0.29 | -0.18 | 0.08 |
| Income before tax | 7.23 | 2.37 | 2.25 | 10.01 | 2.54 |
| Net income | 7.23 | 2.37 | 2.25 | 10.01 | 2.54 |
Show Quarterly Income Statement
Income Statement - Anbio Biotechnology (NNNN)
$(Billion, Million)| Mar-26 | Jun-25 | Dec-24 | Jun-24 | Dec-23 | Jun-23 | |
|---|---|---|---|---|---|---|
| Total revenue | 4.74 | 5.01 | 2.53 | 6.32 | 3.95 | 3.31 |
| Cost of revenue | 0.88 | 0.38 | 0.39 | 2.10 | 2.26 | 1.36 |
| Gross profit | 3.86 | 4.62 | 2.14 | 4.23 | 1.69 | 1.94 |
| Total operating expenses | 1.06 | 0.95 | 3.87 | 0.34 | 1.11 | 0.41 |
| Operating income | 2.80 | 3.68 | -1.74 | 3.89 | 0.58 | 1.54 |
| Non-operating income (net) | 0.24 | 0.47 | 0.41 | 0.00 | 0.21 | 0.11 |
| Income before tax | 3.04 | 4.15 | -1.32 | 3.89 | 0.79 | 1.64 |
| Net income | 3.04 | 4.15 | -1.32 | 3.89 | 0.79 | 1.64 |